Difference between revisions of "Team:IIT Delhi/InterLab"

Line 22: Line 22:
 
.bgimg-1, .bgimg-2, .bgimg-3, .bgimg-5, .bgimg-4 {
 
.bgimg-1, .bgimg-2, .bgimg-3, .bgimg-5, .bgimg-4 {
 
   position: relative;
 
   position: relative;
   opacity: 1;
+
   opacity: 0.65;
 
   background-attachment: fixed;
 
   background-attachment: fixed;
 
   background-position: center;
 
   background-position: center;
Line 30: Line 30:
 
}
 
}
 
.bgimg-1 {
 
.bgimg-1 {
   background-image: url("https://static.igem.org/mediawiki/2018/f/ff/T--IIT_Delhi--white.jpeg");
+
   background-image: url("https://static.igem.org/mediawiki/2018/e/e7/T--IIT_Delhi--InterlabPlate.jpeg");
   min-height: 100px;
+
   min-height: 300px;
 
}
 
}
  
Line 931: Line 931:
 
<div class="bgimg-1">
 
<div class="bgimg-1">
 
   <div class="caption">
 
   <div class="caption">
     <span class="border" >UNESP Brazil</span>
+
     <span class="border" >Fifth International InterLab Measurement Study</span>
 
   </div>
 
   </div>
 
</div>
 
</div>
Line 939: Line 939:
 
   
 
   
  
<p style="font-size:20px;font-family: 'Lato', sans-serif;font-weight:400;"><img src="https://static.igem.org/mediawiki/2018/d/dc/T--IIT_Delhi--UNESP_Brazil.png" alt="Smiley face" style="float:right;width:600px;margin:15px">
+
<p style="font-size:20px;font-family: 'Lato', sans-serif;font-weight:400;">
We collaborated with iGEM UNESP Brazil is working on the subject of <b>Engineered Probiotics Around the World.</b>
+
The Measurement Committee, through the InterLab study, has been developing a robust measurement procedure for green fluorescent protein (GFP) over the last several years.
<br>The goal of the collaboration was to understand about the GMO legislation around the world and if there already is any regulations about engineered probiotics and if there are clinical trials or companies using engineered probiotics in these countries. This work was done in collaboration with teams Chalmers-Gothenburg, IIT Delhi, Jiangnan China, TecCEM and Lambert. We were grateful that they reached out to us. It was really interesting to learn about probiotics marketed in various countries, high tech startups working in the field of probiotics and recent clinical trials across the world that provide critical insight into a topic that has been of much importance recently. The data from the collaboration is given below,<br>
+
  
<b>China</b><br>
+
The goal of the iGEM InterLab Study is to identify and correct the sources of systematic variability in synthetic biology measurements, so that eventually, measurements that are taken in different labs will be no more variable than measurements taken within the same lab. Until we reach this point, synthetic biology will not be able to achieve its full potential as an engineering discipline, as labs will not be able to reliably build upon others’ work.  
In China, there is no regulation for genetically engineered probiotics, the present tests in the country approach pathogenic potential, and patronized standards for food evaluation. No companies or clinical trials that use engineered probiotics has come to our knowledge.<br>
+
  
<b>India</b><br>
+
In the previous studies, we showed that by measuring GFP expression in absolute fluorescence units calibrated against a known concentration of fluorescent molecule, we can greatly reduce the variability in measurements between labs. However, when we take bulk measurements of a population of cells (such as with a plate reader), there is still a large source of variability in these measurements: the number of cells in the sample.  
In India, the ICMR (Indian Council of Medical Research) in partnership with DBT (Department of Biotechnology), created an official guide to evaluate probiotics in the country, so any probiotic product needs to be on this guide´s pattern to be released in the market.<br>
+
Before being approved and released, food is submitted to standardized tests for identification and characterization of its new chains, such as PCR, in vitro tests mimicking the gut environment, in vivo testing to check the effectiveness in live animals, safety assessment for human use, evaluation of efficacy in humans, also there are standards patterns that need to be followed for the process of food packing and management.<br>
+
Currently, the probiotic market in India is dominated by multinationals, which mainly commercialize fermented food products. No companies or clinical trials that use engineered probiotics has come to our knowledge.<br>
+
  
<b>Mexico</b><br>
+
Because the fluorescence value measured by a plate reader is an aggregate measurement of an entire population of cells, we need to divide the total fluorescence by the number of cells in order to determine the mean expression level of GFP per cell. Usually we do this by measuring the absorbance of light at 600nm, from which we compute the “optical density (OD)” of the sample as an approximation of the number of cells. OD measurements are subject to high variability between labs, however, and it is unclear how good of an approximation an OD measurement actually is. If we used a more direct method to determine the cell count in each sample, then potentially we could remove another source of variability in our measurements.  
In Mexico, all food that has been processed or produced by genetically modified organisms are considered transgenic, but food containing GM or transgenic compounds are not identified, even though there are biosecurity laws and norms for regulation, such as SEP, CIBIOGEM, SAGARPA, SEMARNAT, SHCP and the Federal Law for Protection of the Consumer.<br>
+
In terms of the norm, the Official Mexican, Norm NOM-056-FITO-1995, is in force and regulates everything related to GM mobilization in the country, so all public and private company must fulfill the requirements in the norm to have their food with genetically engineered compounds transit through Mexico. Furthermore, the law of Biosecurity of GMO and the Federal Law for Protection of the Consumer controls the release for consumption and commercialization of pilot projects besides regulating importation and exportation of GM in the country. No companies or clinical trials that use engineered probiotics has come to our knowledge.<br>
+
  
<b>Sweden</b><br>
+
Converting between absorbance of cells to absorbance of a known concentration of beads.
In Sweden every substance or combination of substances that is provided under the pretense that it has a preventative or therapeutic effect on diseases in humans or animals states for a pharmaceutical, which is regulated by the Swedish Medical Products Agency (MPA). When this kind of probiotic is been prepared to be released the Swedish Gene Technology Advisory Board and the Swedish National Council of Medical Ethics are often involved and give out statements and input in regards to the applications for clinical trials. There all pharmaceuticals that contain any modified organism need to be labeled with “This product contains (a) genetically modified organism(s)”, and all of the trials regarding GM pharmaceuticals are posted on the Swedish Medical Products Agency’s website. In Europe, the following company working with engineered probiotics has come to our knowledge: ActoBio Therapeutics (part of Intrexon) in Belgium.<br>
+
  
<b>United States</b><br>
+
Absorbance measurements use the way that a sample of cells in liquid scatter light in order to approximate the concentration of cells in the sample. In this year’s Measurement Kit, we provide you with a sample containing silica beads that are roughly the same size and shape as a typical E. coli cell, so that it should scatter light in a similar way. Because we know the concentration of the beads, we can convert each lab’s absorbance measurements into a universal, standard “equivalent concentration of beads” measurement.
Engineered probiotics are not regulated by the US Food and Drug Administration, as they are neither a food nor a drug. As a result, they currently do not require large clinical trials like other drugs in America.
+
The following companies working with engineered probiotics has come to our knowledge: Azitra, Synlogic and ZBiotics.<br>
+
  
 +
2. Counting colony-forming units (CFUs) from the sample.
 +
 +
A simple way to determine the number of cells in a sample of liquid media is to pour some out on a plate and see how many colonies grow on the plate. Since each colony begins as a single cell (for cells that do not stick together), we can determine how many live cells were in the volume of media that we plated out and obtain a cell concentration for our sample as a whole. We will have you determine the number of CFUs in positive and negative control samples in order to compute a conversion factor from absorbance to CFU.
  
<b>Brazil</b><br>
 
There exists no law that regulates genetically engineered probiotics, but in 2018 ANVISA, the Brazilian National Health Surveillance Agency, opened up the public consultation and now genetically engineered probiotics were added to the regulation. Besides, there is no companies or clinical trials that use engineered probiotics.
 
With this research, we were able to see that there is a growing movement of engineered probiotics mostly in the U.S., but that there still is a lack of laws and regulation all over the world to regulate these products before they can reach the market and the final consumers.<br>
 
 
</p>
 
</p>
 
      
 
      
 
</div>
 
</div>
  
<div class="bgimg-2">
 
  <div class="caption">
 
    <span class="border" >Shiv Nadar University</span>
 
  </div>
 
</div>
 
  
<div style="position:relative;">
 
  <div style="color: #777;background-color:white;text-align:center;padding:50px 80px;text-align: justify;">
 
 
<p style="font-size:20px;font-family: 'Lato', sans-serif;font-weight:400;"><img src="https://static.igem.org/mediawiki/2018/9/9f/T--IIT_Delhi--shiv.png" alt="Smiley face" style="float:right;width:600px;margin:15px">
 
Genesis, The Life Sciences Department of Shiv Nadar University is interested in setting up an iGEM team for 2019. We are currently mentoring them after they reached out to us through our social media accounts. We had an illuminating mentoring session with them in this aspect where we discussed in detail the prerequisites for participating in iGEM competition as well as a discussion regarding Human Practices, Safety, Funding, iBEC and Track selection. It was a great experience for both the teams. We wish Team Shiv Nadar best of luck for their future endeavors and look forward to work alongside them in the coming year. </p>
 
 
 
 
 
  </div>
 
</div>
 
 
<div class="bgimg-3">
 
  <div class="caption">
 
    <span class="border">iGEM LabPats</span>
 
  </div>
 
</div>
 
 
<div style="position:relative;">
 
  <div style="color: #777;background-color:white;text-align:center;padding:50px 80px;text-align: justify;">
 
 
      <p style="font-size:20px;font-family: 'Lato', sans-serif;font-weight:400;"><img src="https://static.igem.org/mediawiki/2018/a/a0/T--IIT_Delhi--LabPats.png" alt="Smiley face" style="float:left;height:700px;margin:15px">During the summers, we had a skype session with iGEM Labpats - a student team from Carroll High School, U.S.A. We talked about our project and exchanged design ideas. We discussed the possible ways in which human practices could be conducted in an impactful manner. The discussion was really stimulating and gave us some great ideas for our human practices. iGEM IIT Delhi being a collegiate team was amazed to see the dedication of these school students. We wish them our best in their future endeavors. </p>
 
  </div>
 
</div>
 
 
<div class="bgimg-5">
 
  <div class="caption">
 
    <span class="border">InterLab Troubleshooting</span>
 
  </div>
 
</div>
 
 
<div style="position:relative;">
 
  <div style="color: #777;background-color:white;text-align:center;padding:50px 80px;text-align: justify;">
 
 
      <p style="font-size:20px;font-family: 'Lato', sans-serif;font-weight:400;"> We faced some problems during our InterLab characterization, our absorbance at 600nm for silica beads at high dilutions didn't follow the trend. Upon which, we discussed the problem on All India iGEM group, where the teams gave us multiple suggestions and shared their protocols by which we were able to obtain our results as deisred by iGEM. Hence, we would like to express our gratitude towards the Indian iGEM teams.
 
 
</p>
 
 
 
 
 
 
  </div>
 
</div>
 
  
 
     <!--/**/-->
 
     <!--/**/-->

Revision as of 10:41, 17 October 2018

iGEM IIT Delhi

Fifth International InterLab Measurement Study

The Measurement Committee, through the InterLab study, has been developing a robust measurement procedure for green fluorescent protein (GFP) over the last several years. The goal of the iGEM InterLab Study is to identify and correct the sources of systematic variability in synthetic biology measurements, so that eventually, measurements that are taken in different labs will be no more variable than measurements taken within the same lab. Until we reach this point, synthetic biology will not be able to achieve its full potential as an engineering discipline, as labs will not be able to reliably build upon others’ work. In the previous studies, we showed that by measuring GFP expression in absolute fluorescence units calibrated against a known concentration of fluorescent molecule, we can greatly reduce the variability in measurements between labs. However, when we take bulk measurements of a population of cells (such as with a plate reader), there is still a large source of variability in these measurements: the number of cells in the sample. Because the fluorescence value measured by a plate reader is an aggregate measurement of an entire population of cells, we need to divide the total fluorescence by the number of cells in order to determine the mean expression level of GFP per cell. Usually we do this by measuring the absorbance of light at 600nm, from which we compute the “optical density (OD)” of the sample as an approximation of the number of cells. OD measurements are subject to high variability between labs, however, and it is unclear how good of an approximation an OD measurement actually is. If we used a more direct method to determine the cell count in each sample, then potentially we could remove another source of variability in our measurements. Converting between absorbance of cells to absorbance of a known concentration of beads. Absorbance measurements use the way that a sample of cells in liquid scatter light in order to approximate the concentration of cells in the sample. In this year’s Measurement Kit, we provide you with a sample containing silica beads that are roughly the same size and shape as a typical E. coli cell, so that it should scatter light in a similar way. Because we know the concentration of the beads, we can convert each lab’s absorbance measurements into a universal, standard “equivalent concentration of beads” measurement. 2. Counting colony-forming units (CFUs) from the sample. A simple way to determine the number of cells in a sample of liquid media is to pour some out on a plate and see how many colonies grow on the plate. Since each colony begins as a single cell (for cells that do not stick together), we can determine how many live cells were in the volume of media that we plated out and obtain a cell concentration for our sample as a whole. We will have you determine the number of CFUs in positive and negative control samples in order to compute a conversion factor from absorbance to CFU.

Contact us

Address

Undergraduate Laboratory
Department of Biotechnology and Biochemical Engineering, IIT Delhi